In conclusion, our results demonstrate that RPL35A binds to MYC via its 2 to 22 amino acid residues, thereby facilitating MYC-dependent SKP2 transcription, enhancing glycolysis, and promoting tumor progression. The gene discussed is RPL35A; the disease is neoplasm.